Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor. Download Section Flyer
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- HNSCC Chemotherapy: What We Know and New Perspectives (Deadline: 31 July 2024)
- Ophthalmic Pharmacology (Deadline: 6 August 2024)
- Melatonin in Cancer Treatment (Deadline: 10 August 2024)
- Optimized or Precise Pharmacological Treatment of Bipolar Disorder (Deadline: 15 August 2024)
- Calcium Channels as Therapeutic Targets (Deadline: 15 August 2024)
- Novel Therapeutic Target for Hepatocellular Carcinoma (Deadline: 15 August 2024)
- Small Molecules in Targeted Cancer Therapy and Diagnosis (Deadline: 20 August 2024)
- The Pharmacological Management of Bone and Muscle Disorders (Deadline: 20 August 2024)
- Pharmacotherapy of Neuropathic Pain (Deadline: 20 August 2024)
- Novel Strategies in Gangliosidoses Therapy (Deadline: 22 August 2024)
- Oncolytic Viruses: New Cancer Immunotherapy Drugs (Deadline: 25 August 2024)
- Population Pharmacokinetic and Pharmacodynamic and Clinical Strategies (Deadline: 25 August 2024)
- Therapeutic Potential for Cannabinoid and Its Receptor (Deadline: 25 August 2024)
- The 20th Anniversary of Pharmaceuticals—Advances in Pharmacology (Deadline: 25 August 2024)
- Drug Candidates for the Treatment of Atopic Dermatitis (Deadline: 25 August 2024)
- Infectious Disease Epidemiology and Pharmaceutical Development (Deadline: 30 August 2024)
- Recent Advances in TGF-β Inhibitors for the Therapeutic Management of Cancer and Fibrosis (Deadline: 30 August 2024)
- Rodent Animal Models for Drug Discovery (Deadline: 30 August 2024)
- Potassium Channels as Novel Therapeutic Targets (Deadline: 30 August 2024)
- Pharmacotherapy of Thromboembolism (Deadline: 31 August 2024)
- Tumor Immunopharmacology (Deadline: 9 September 2024)
- Pharmacological Treatment of Colorectal Cancer (Deadline: 15 September 2024)
- Affective Disorders Psychopharmacology (Deadline: 20 September 2024)
- Drug Candidates for Allergic Diseases (Deadline: 20 September 2024)
- Pharmacovigilance in Drug Therapy: Drug–Drug Interactions and Safety Evaluation (Deadline: 20 September 2024)
- Targeting Apoptosis as a Strategy for Developing New Drugs (Deadline: 20 September 2024)
- Ion Channel Pharmacology (Deadline: 22 September 2024)
- Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma 2024 (Deadline: 23 September 2024)
- The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement (Deadline: 25 September 2024)
- Pharmacotherapy for Macular Diseases 2024 (Deadline: 25 September 2024)
- Recent Advances in Psychopharmacology (Deadline: 25 September 2024)
- New Perspectives in Ocular Pharmacology (Deadline: 25 September 2024)
- Advances in Neuropharmacology of Drug Abuse (Deadline: 25 September 2024)
- 20th Anniversary of Pharmaceuticals—Met Receptor (Deadline: 25 September 2024)
- Drug Resistance Against Cancer Treatment (Deadline: 25 September 2024)
- Medications: Interactions with Diet, Herbs, Dietary Supplements and Probiotics (Deadline: 27 September 2024)
- Drug Safety and Risk Management in Clinical Practice (Deadline: 30 September 2024)
- Advancements in Cardiovascular and Antidiabetic Drug Therapy (Deadline: 30 September 2024)
- Membrane Transporters in Drug Development: Recent Advances (Deadline: 13 October 2024)
- Novel Therapeutic Approaches for Cystic Fibrosis (Deadline: 20 October 2024)
- Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success (Deadline: 20 October 2024)
- Pharmacotherapy for Neuropathic Pain (Deadline: 20 October 2024)
- Adjuvant Therapies for Cancer Treatment (Deadline: 20 October 2024)
- Pharmacotherapy of Neurodegeneration Disorders (Deadline: 20 October 2024)
- Current Therapies for Endometriosis, Adenomyosis and Endometrial Cancer (Deadline: 22 October 2024)
- Use of Anesthetic Agents: Management and New Strategy (Deadline: 22 October 2024)
- Data-Driven Biomarker and Drug Discovery for Complex Disease (Deadline: 22 October 2024)
- New Insights into Therapy for Alzheimer’s and Other Neurodegenerative Diseases (Deadline: 22 October 2024)
- Pharmacogenomics for Precision Medicine (Deadline: 23 October 2024)
- Antimycobacterial Agents: New Advances in Combating Drug-Resistant Tuberculosis (Deadline: 25 October 2024)
- New Targets and Experimental Therapeutic Approaches for Cancers (Deadline: 25 October 2024)
- Lithium in Psychiatric Therapy: Celebrating 75th Anniversary (Deadline: 25 October 2024)
- From Bench to Bedside: Expanding the Scope of Thioredoxin Reductase Inhibitors as Promising Therapeutics for Tumors, Inflammatory Disorders, and Infectious Diseases (Deadline: 25 October 2024)
- Novel Antimicrobials and the Antimicrobial Activity: New Advances (Deadline: 25 October 2024)
- Exploring Natural Products as Modulators of Oxidative Stress in Health and Disease (Deadline: 25 October 2024)
- P2X Receptors and Their Pharmacology (Deadline: 25 October 2024)
- Drug-Induced and Herbal Hepatotoxicity and Methods of Its Prevention (Deadline: 29 October 2024)
- Novel Therapeutic Targets and Approaches for the Treatment for Alzheimer's Disease (Deadline: 30 October 2024)
- Pharmacotherapy for Alzheimer’s Disease (Deadline: 30 October 2024)
- Fluoroquinolones (Deadline: 31 October 2024)
- DHA and EPA in Health and Disease (Deadline: 31 October 2024)
- New and Emerging Treatment Strategies for Gastrointestinal Diseases (Deadline: 31 October 2024)
- Drug Treatment of Cholangiocarcinoma (Deadline: 5 November 2024)
- Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances (Deadline: 10 November 2024)
- Antidepressant Drug (Deadline: 15 November 2024)
- New Advances in Antiarrhythmic Drugs (Deadline: 15 November 2024)
- Pharmacology and Toxicology of Opioids (Deadline: 20 November 2024)
- Psychedelics: A New Drug Candidate for Treating Mental Illness (Deadline: 20 November 2024)
- Advances in Pharmacotherapy of Neuropathic Pain (Deadline: 20 November 2024)
- Molecular Mechanisms and Therapeutic Resistance in Cancer: Insights from Transcriptional Regulation and Immune Modulation (Deadline: 20 November 2024)
- New Findings in Pharmacogenomics of Neuropsychiatric Disorders (Deadline: 23 November 2024)
- Pharmacotherapy of Inflammatory Bowel Disease (Deadline: 23 November 2024)
- Exploring Biomarkers and Pharmacotherapies for Substance Use Disorders (Deadline: 25 November 2024)
- Ion Channels as Pharmacological Targets in Cancer (Deadline: 25 November 2024)
- Smooth Muscle and Endothelial Cells as Pharmacological Targets for Acute Oxidative Stress (Deadline: 25 November 2024)
- Advances in Mass Spectrometry Metrology in Pharmaceutical Sciences (Deadline: 25 November 2024)
- NeuroImmunoEndocrinology (Deadline: 25 November 2024)
- Pharmacotherapy for Retinopathy (Deadline: 25 November 2024)
- Pharmacoepidemiology and Pharmacovigilance in Drug Therapy: New Issues, Challenges, and Applications (Deadline: 25 November 2024)
- Dopamine and Serotonin Receptors: Selective or Multitarget Ligands for the Treatment of Central Nervous System Diseases (Deadline: 25 November 2024)
- Pharmacological Insight into NMDA Receptor Antagonists (Deadline: 25 November 2024)
- Toxicological Effects of Drug Abuse and Its Consequences on Health (Deadline: 28 November 2024)
- Application of Gastrointestinal Peptides in Medicine (Deadline: 29 November 2024)
- Innovative Tools for Drug Analysis and Therapeutic Drug Monitoring (TDM) (Deadline: 30 November 2024)
- HTLV-1: Molecular Insights to Targeted Elimination Strategies (Deadline: 30 November 2024)
- Potential Therapeutic Targets for the Treatment of Pathological Pain (Deadline: 30 November 2024)
- Discovery of Novel Antidepressants and Anxiolytics (Deadline: 30 November 2024)
- Barrier Dynamics and Immune Interplay in Brain Aging and Injury (Deadline: 30 November 2024)
- Recent Advances in Behavioral Psychopharmacology (Deadline: 15 December 2024)
- Wnt Signaling in Cancer: New Advances (Deadline: 20 December 2024)
- Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2023 (Deadline: 20 December 2024)
- Pharmacotherapy for Schizophrenia: New Advances (Deadline: 22 December 2024)
- Pharmaceutical Potential of Selenium (Deadline: 25 December 2024)
- Recent Advances in Ocular Pharmacology (Deadline: 25 December 2024)
- The Pharmacology of Bisphosphonates: New Advances (Deadline: 25 December 2024)
- Current Pharmacotherapy for Viral Hepatitis (Deadline: 31 December 2024)
- Biomarkers and Therapeutic Targets for Melanoma (Deadline: 31 December 2024)
- Biological and Pharmacological Research on Indole-3-Carbinol (I3C) and Its Derivatives (Deadline: 15 January 2025)
- Exploring the Anticancer and Immunomodulatory Mechanisms of Phytochemicals and Natural Bioactive Compounds (Deadline: 15 January 2025)
- Therapeutic Potential of Chalcone Derivatives (Deadline: 15 January 2025)
- Pharmacotherapy of Gastric Cancer (Deadline: 20 January 2025)
- Sirtuins as Novel Biological Targets for Pharmacological Intervention in Physiology and Pathology (Deadline: 25 January 2025)
- Molecular Mechanisms and Treatment of Brain Cancer: Recent Advances and Future Trends (Deadline: 31 January 2025)
- Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria (Deadline: 31 January 2025)
- Osteosarcomas: Treatment Strategies, 2nd Edition (Deadline: 31 January 2025)
- New Street Opioids, Their Mixtures and Emerging Interventions (Deadline: 10 February 2025)
- Recent Advances in Cancer Diagnosis and Therapy (Deadline: 30 July 2025)
Topical Collection
Following topical collection within this section is currently open for submissions: